Delivery Order SPE2DB22D1103-SPE2DB25FH1B8
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $1,783.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract through open competition. The order is scheduled for completion by July 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Abiraterone Acetate 250 mg tablets in quantities of 120 units, with a ceiling value of $139,580.38. This firm fixed-price delivery order, with an ultimate completion date of April 23, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $25,102.49. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a pediatric delivery against AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.10 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,745.56 delivery order to AmerisourceBergen Drug Corp for Abiraterone Acetate 250 mg tablets (120-count supply) under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside order represents a competitive award to support federal medical procurement needs, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120 count) with a contract ceiling value of $96,424.70. This competitive award employs firm fixed pricing and requires completion by September 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH1B8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a contract value of $13,351.40. The award, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is executed under AmerisourceBergen Drug Corp's prime Indefinite Delivery/Indefinite Quantity contract (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for the Defense Logistics Agency's global medical supply operations. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of drug products and medical supplies supporting the Defense Health Agency and other government healthcare systems. The abiraterone acetate delivery fulfills ongoing pharmaceutical procurement requirements within the DLA's medical supply chain supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 8/26/25 |